Jennifer Pietenpol

The announcement of the recognition of VMAC as an NIH Center of Excellence comes nearly five years after the creation of an exploratory NIA-funded Alzheimer’s Disease Research Center. Read More

Vanderbilt University has awarded a new cycle of Innovation Catalyst Fund grants to pioneering faculty projects that advance health care technology, AI tools for research impact and wearable devices. These grants support translational research and drive real-world solutions across disciplines, underscoring Vanderbilt's commitment to fostering innovation and societal impact. Read More

Vanderbilt has announced the February 2024 Innovation Catalyst Fund awardees, propelling groundbreaking research into practical applications. Read More

Vanderbilt University School of Medicine, which received $527.7 million in direct and indirect NIH grant support in FY23, has been among the top 10 U.S. medical schools in NIH funding for six of the last 10 years. Read More

Jennifer Pietenpol, Ingram Professor of Cancer Research and professor of biochemistry, is the 2024 recipient of the Science of Oncology Award, which is presented annually to an individual who has made outstanding contributions to basic or translational research in cancer. Read More

The Vanderbilt Innovation Catalyst Fund honors eight projects in its inaugural pre-seed funding round, showcasing the university’s commitment to transforming research into real-world solutions. Read More

Vanderbilt University's Innovation Catalyst Fund, dedicated to advancing translational research, begins accepting applications Sunday, Oct. 1. This transformative initiative, bridging research, innovation and real-world solutions, invites faculty across all disciplines to submit groundbreaking research proposals by Oct. 31. Read More

  by Bill Snyder In a multidisciplinary collaboration, researchers at Vanderbilt University Medical Center and the University of Miami Miller School of Medicine have identified a subtype of triple-negative breast cancer (TNBC) that appears to be able to escape detection by the immune system and evade immunotherapy. Their report, published Nov. 1 in the journal... Read More

The Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) recently moved into its new research and administrative home. Read More

As Nashville cautiously begins to emerge from its two-month-long COVID-19 Safer at Home response, so too are the labs and facilities at Vanderbilt University Medical Center. Read More

Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation. Read More

Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat. Read More

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding. Read More

Vanderbilt-Ingram Cancer Center scientists have discovered a role for a tumor suppressor protein in skin wound healing. Read More

A multidisciplinary cross section of the Vanderbilt University Medical Center and Vanderbilt University community gathered Tuesday during StrategyShare18, an interactive half-day event to share ideas, invite collaborations and spur new initiatives. Read More

Vanderbilt University Medical Center (VUMC) on Monday held its first Directorship Celebration to honor and support eight of its leaders in clinical care, research, education and administration. Read More

Members of the Vanderbilt University Medical Center (VUMC) community and others whose lives and careers have been influenced by legendary cancer investigator, educator and administrator Harold (Hal) Moses, M.D., have endowed the Linda and Harold L. Moses, M.D. Career Development Fund. Read More

On the same day 48 years after the July 20, 1969, Apollo 11 moon landing, individuals from throughout the Vanderbilt community reflected on that historic event — a milestone marking the ultimate synthesis of innovative thinking and technology — as they shared their own explorations and mission moments during StrategyShare17. Read More

Nearly 400 members of the Canby Robinson Society and the Vanderbilt University Medical Center (VUMC) community joined together at Cheekwood Estate and Gardens recently for a reception celebrating the Medical Center’s shared commitment to healthy communities and to pioneer the future of health care. Read More

Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC) and director of Vanderbilt-Ingram Cancer Center (VICC), has been named a Chief Scientific Advisor (CSA) for the nonprofit breast cancer organization Susan G. Komen. Read More